Applications invited for the post of Junior Research Fellow at National Institute of Immunology
The National Institute of Immunology (NII) is an autonomous institution supported by the Department of Biotechnology, Government of India. The Institute is committed to advanced research addressing the basic mechanisms involved in body's defense, host-pathogen interactions and related areas with a view to contribute to the creation of an internationally competitive intellectual knowledge base as a sustainable source of innovative futuristic modalities of potential use in health care.
Post : Junior Research Fellow
The Indian National Science Academy (INSA) was established in January 1935 with the object of promoting science in India and harnessing scientific knowledge for the cause of humanity and national welfare. The foundation of the Academy, earlier known as the National Institute of Sciences of India (NISI), was the outcome of joint endeavours of several organizations and individuals and the Indian Science Congress Association (ISCA) playing a leading role in this regard.
The Indian Institute of Technology Kanpur was established in the year 1960. The Parliament of India passed the ‘Institutes of Technology Act 1961’ declaring all the IITs as “Institutions of National Importance”. The Parliamentary Act has given absolute autonomy to the IITs. When the foundation stone of the IIT system was laid, it was perceived that taking help from the industrially advanced western countries might be lot more effective in achieving the status of a world class technical institute. Hence, IIT Kanpur had a massive collaboration with USA through a specially created programme- KIAP (Kanpur Indo American Programme).
A global healthcare leader, Novartis has one of the most exciting product pipelines in the industry today. A pipeline of innovative medicines brought to life by diverse, talented and performance driven people. All of which makes them one of the most rewarding employers in their field.
Covance, a $15 billion Fortune 500 company, with operations in over 97 countries, has led the way in improving patient outcomes through visionary data sciences over the last five decades. We have supported 100% of the top 50 drugs in the market and all the oncology medicines approved in 2016. Our team of over 57,000 across the globe is committed to advancing healthcare and bringing new medicines to market sooner. Our unique perspectives, built from decades of scientific expertise and precision delivery, help our clients identify new approaches and anticipate tomorrow’s challenges as they evolve. Driven by a passion for excellence and a relentless commitment to quality, we unlock opportunities that advance innovation and deliver the promise of a healthier world. Together, with our large pharmaceutical and emerging biotech clients, Covance transforms today's health care challenges into tomorrow's solutions.
